Astrazeneca ADR Stock
€78.50
Your prediction
Astrazeneca ADR Stock
Pros and Cons of Astrazeneca ADR in the next few years
Pros
Cons
Performance of Astrazeneca ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Astrazeneca ADR | 1.290% | - | - | - | - | - | - |
| GSK plc ADR | -0.810% | 1.646% | 13.825% | 41.143% | 18.182% | 47.024% | 35.342% |
| UCB S.A. | -0.080% | -0.676% | 3.201% | 39.968% | 11.373% | 234.430% | 203.629% |
| Novartis AG ADR | 0.750% | 3.846% | 10.656% | 29.808% | 13.924% | 66.667% | 77.632% |
News
1 Quantum Computing Stock to Buy that Could Soar in 2026
Quantum computing is moving from the theoretical to the commercially applicable, but only one company has achieved 99.99% two-qubit gate fidelity (a measure of results accuracy). That company is
3 Absurdly Cheap Stocks You Can Buy For Less than $100 Right Now
Valuations for many stocks are sky-high, and that can make now an unappealing time to invest in the stock market. However, there are still some great value buys that don't involve taking on a lot of
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards
MIAMI, FLORIDA / ACCESS Newswire / December 16, 2025 / AstraZeneca, Eastman, Kraft Heinz, and P&G have been recognized for their outstanding contribution at the recent OMP Conference. The


